Skip to content

A Retrospective Study on the Clinical Features and Management of Patients with Birt-Hogg-Dubé Syndrom

A Retrospective Study on the Clinical Features and Management of Patients with Birt-Hogg-Dubé Syndrom

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122539
Enrollment
Unknown
Registered
2026-04-15
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Birt-Hogg-Dubé Syndrome

Interventions

Research group:None

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with Birt-Hogg-Dubé syndrome through clinical examination, genetic testing (pathogenic mutations in the FLCN gene), or pathological examination; 2.Age is not a factor and both men and women are welcome. 3.The medical record is complete and should at least include the following core information: demographic characteristics, age of onset, disease course, clinical symptoms (characteristics of skin lesions, systemic involvement), laboratory tests, imaging/pathological examination results, family history, treatment plan, and follow-up records.The medical record is complete and should at least include the following core information: demographic characteristics, age of onset, disease course, clinical symptoms (characteristics of skin lesions, systemic involvement), laboratory tests, imaging/pathological examination results, family history, treatment plan, and follow-up records.

Exclusion criteria

Exclusion criteria: 1.Those who are clinically suspected of having BHD syndrome but have not been confirmed by genetic or pathological examination. 2.Clinical medical records with incomplete data, lacking key information such as core clinical manifestations, treatment plans, and follow-up outcomes, and thus unable to meet the requirements for research analysis; 3.There were no clear follow-up records, or the patients withdrew voluntarily or were lost to follow-up during the follow-up period, making it impossible to obtain information on therapeutic effects and prognosis.

Design outcomes

Primary

MeasureTime frame
Clinical manifestations;

Secondary

MeasureTime frame
Blood routine;Liver and kidney function;

Countries

China

Contacts

Public ContactTao Wang

Peking Union Medical College Hospital

wangtaopumch@126.com+86 10 6915 1502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026